Reprogramming cancer stem cells

Journal of Cancer Science and Therapy

Volumn 4, Issue 12, 2012, Pages

  Tafani, Marco ^a   Russo, Matteo A ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 4; MICRORNA; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

CANCER STEM CELL; CELL ONCOGENE; EDITORIAL; EMBRYONIC STEM CELL; FIBROBLAST CULTURE; GENE EXPRESSION; HUMAN; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; TUMOR GROWTH;

EID: 84872405099     PISSN: None     EISSN: 19485956     Source Type: Journal    
DOI: 10.4172/1948-5956.1000e116     Document Type: Editorial

References (15)

1. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
2. Maherali N, Hochedlinger K (2008) Guidelines Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3: 595-605.
3. Cherry AB, Daley GQ (2012) Reprogramming cellular identity for regenerative medicine. Cell 148: 1110-1122.
4. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, et al. (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7: 618-630.
5. Kuo CH, Ying SY (2012) Advances in microRNA-mediated reprogramming technology. Stem Cells Int.
6. Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, et al. (2010) Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet 42: 1113-1117.
7. Yamanaka S (2012) Induced pluripotent stem cells: past, present, and future. Cell Stem Cell 10: 678-684.
8. Ang YS, Gaspar-Maia A, Lemischka IR, Bernstein E (2011) Stem cells and reprogramming: breaking the epigenetic barrier? Trends in Pharmac Sci 32: 394-401.
9. Han SS, Williams LA, Eggan KC (2012) Constructing and deconstructing stem cell models of neurological disease. Neuron 70: 626-644.
10. Marchetto MC, Carromeu C, Acab A, Yu D, Yeo GW, et al. (2010) A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143: 527-539.
11. Spike BT, Wahl GM (2011) p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome. Genes Cancer 2: 404-419.
12. Dewi D, Ishii H, Haraguchi N, Nishikawa S, Kano Y, et al. (2012) Reprogramming of gastrointestinal cancer cells. Cancer Sci 103: 393-399.
13. Heddleston JM, Li Z, McLendon RE, Hjelmeland AB, Rich JN (2009) The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 15: 3274-3284.
14. Zhang X, Cruz FD, Terry M, Remotti F, Matushansky I (2012) Terminal differentiation and loss of tumorigenicity of human cancers via pluripotencybased reprogramming. Oncogene.
15. Vêncio EF, Nelson AM, Cavanaugh C, Ware CB, Milller DG, et al. (2012) Reprogramming of prostate cancer-associated stromal cells to embryonic stem-like. Prostate 72: 1453-1463.